$CYDY: CytoDyn and Samsung BioLogics Enter into Agreement to Manufacture $1 Billion Worth of Leronlimab (PRO 140) to Meet Expected Demand for Future Revenues Post-Approval
https://www.otcmarkets.com/stock/CYDY/news/Cy...?id=223479
(1)
(0)
Sojourner here following God, obeying God, and cleaving to Him. The journey is onward.